195 related articles for article (PubMed ID: 34561301)
1. Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies.
Gkikas D; Stellas D; Polissidis A; Manolakou T; Kokotou MG; Kokotos G; Politis PK
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34561301
[TBL] [Abstract][Full Text] [Related]
2. Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A.
Foskolou IP; Stellas D; Rozani I; Lavigne MD; Politis PK
Oncogene; 2013 Feb; 32(8):947-60. PubMed ID: 22508481
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
Qi J; Pan L; Yu Z; Ni W
Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor subfamily 5 group A member 2 (NR5A2): role in health and diseases.
Sandhu N; Rana S; Meena K
Mol Biol Rep; 2021 Dec; 48(12):8155-8170. PubMed ID: 34643922
[TBL] [Abstract][Full Text] [Related]
5. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor NR5A2 controls neural stem cell fate decisions during development.
Stergiopoulos A; Politis PK
Nat Commun; 2016 Jul; 7():12230. PubMed ID: 27447294
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Receptor NR5A2 Promotes Neuronal Identity in the Adult Hippocampus.
Tsampoula M; Tarampoulous I; Antoniadou I; Koutmani Y; Gkikas D; Vekrellis K; Politis PK
Mol Neurobiol; 2021 May; 58(5):1952-1962. PubMed ID: 33411242
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.
Wolter JK; Wolter NE; Blanch A; Partridge T; Cheng L; Morgenstern DA; Podkowa M; Kaplan DR; Irwin MS
Oncotarget; 2014 Jan; 5(1):161-72. PubMed ID: 24389287
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
[TBL] [Abstract][Full Text] [Related]
10. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.
Ding Q; Grammer JR; Nelson MA; Guan JL; Stewart JE; Gladson CL
J Biol Chem; 2005 Feb; 280(8):6802-15. PubMed ID: 15557280
[TBL] [Abstract][Full Text] [Related]
11. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
12. The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines.
Strakova N; Ehrmann J; Dzubak P; Bouchal J; Kolar Z
J Pharmacol Exp Ther; 2004 Jun; 309(3):1239-47. PubMed ID: 14988421
[TBL] [Abstract][Full Text] [Related]
13. ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.
Persson CU; von Stedingk K; Fredlund E; Bexell D; Påhlman S; Wigerup C; Mohlin S
Exp Cell Res; 2020 Mar; 388(2):111845. PubMed ID: 31945318
[TBL] [Abstract][Full Text] [Related]
14. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
[TBL] [Abstract][Full Text] [Related]
15. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
16. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
18. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak H; Ackermann S; Hero B; Kahlert Y; Oberthuer A; Juraeva D; Roels F; Theissen J; Westermann F; Deubzer H; Ehemann V; Brors B; Odenthal M; Berthold F; Fischer M
Cell Death Dis; 2013 Apr; 4(4):e586. PubMed ID: 23579273
[TBL] [Abstract][Full Text] [Related]
19. Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p.
Chen Y; Hu X; Li Y; Zhang H; Fu R; Liu Y; Hu J; Deng Q; Luo Q; Zhang D; Gao N; Cui H
Sci Rep; 2018 Oct; 8(1):15602. PubMed ID: 30349053
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.
Zhang R; Luo H; Wang S; Chen W; Chen Z; Wang HW; Chen Y; Yang J; Zhang X; Wu W; Zhang SY; Shen S; Dong Q; Zhang Y; Jiang T; Lu D; Zhao S; You Y; Liu N; Wang H
Neuro Oncol; 2014 Nov; 16(11):1510-22. PubMed ID: 24951112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
